Syntheses and biological evaluation of novel quinuclidine derivatives as squalene synthase inhibitors.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2003-05-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0968-0896(03)00143-3PMID 12735986
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis.

  2002cited by this paper
• Syntheses of (4,1-benzoxazepine-3-ylidene)acetic acid derivatives and their inhibition of squalene synthase.

  2002cited by this paper
• Identification of novel mammalian squalene synthase inhibitors using a three-dimensional pharmacophore.

  2002cited by this paper
• Syntheses of fused heterocyclic compounds and their inhibitory activities for squalene synthase.

  2002cited by this paper
• Microbial enantioselective ester hydrolysis for the preparation of optically active 4,1-benzoxazepine-3-acetic acid derivatives as squalene synthase inhibitors.

  2002cited by this paper
• Novel 4,1-benzoxazepine derivatives with potent squalene synthase inhibitory activities.

  2002cited by this paper
• CJ-13,981 and CJ-13,982, new squalene synthase inhibitors.

  2001cited by this paper
• Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.

  2000cited by this paper
• Cyclopentanedi- and tricarboxylic acids as squalene synthase inhibitors: syntheses and evaluation.

  1998cited by this paper
• (1 alpha, 2 beta, 3 beta, 4 alpha)-1,2-bis[N-propyl-N-(4-phenoxybenzyl) amino]carbonyl]cyclobutane-3,4-dicarboxylic acid (A-87049): a novel potent squalene synthase inhibitor.

  1997cited by this paper
• alpha-Phosphonosulfonic acids: potent and selective inhibitors of squalene synthase.

  1996cited by this paper
• Chemistry and Biology of the Zaragozic Acids (Squalestatins)

  1996cited by this paper
• Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors.

  1996cited by this paper
• Orally active squalene synthase inhibitors: bis((acyloxy)alkyl) prodrugs of the alpha-phosphonosulfonic acid moiety.

  1996cited by this paper
• Synthetic chemistry. Combating cholesterol.

  1995cited by this paper
• 1,1-Bisphosphonate squalene synthase inhibitors: interplay between the isoprenoid subunit and the diphosphate surrogate.

  1995cited by this paper
• TOTAL SYNTHESES OF ZARAGOZIC ACID

  1995cited by this paper
• Synthetic chemistry. Combating cholesterol.

  1995cited by this paper
• Inhibition of Mammalian Squalene Synthetase Activity by Zaragozic Acid A Is a Result of Competitive Inhibition Followed by Mechanism-based Irreversible Inactivation

  1995cited by this paper
• Inhibitors of squalene biosynthesis and metabolism.

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Inhalation of levomepromazine in severe acute asthma.

  1994cited by this paper
• Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo.

  1993cited by this paper
• N-(arylalkyl)farnesylamines: new potent squalene synthetase inhibitors.

  1993cited by this paper
• Synthesis and characterization of aza analog inhibitors of squalene and geranylgeranyl diphosphate synthases.

  1992cited by this paper
• Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis.

  1992cited by this paper
• The first potent inhibitor of squalene synthase : a profound contribution of an ether oxygen to inhibitor-enzyme interaction

  1991cited by this paper
• Isoprenyl phosphinylformates: new inhibitors of squalene synthetase.

  1991cited by this paper
• SQUALENE SYNTHETASE INHIBITORS : SYNTHESIS OF SULFONIUM ION MIMICS OF THE CARBOCATIONIC INTERMEDIATES

  1991cited by this paper
• Lipoproteins and atherogenesis. Current concepts.

  1990cited by this paper
• HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.

  1990cited by this paper
• Cholesterol and coronary heart disease. Future directions.

  1990cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Pharmacological approaches to the modulation of plasma cholesterol.

  1988cited by this paper
• Highly stereoselective total synthesis of methynolide, the aglycon of the 12-membered macrolide antibiotic methymycin. I. Synthesis of a prelog-djerassi lactone-type chiral intermediate from D-glucose.

  1987cited by this paper
• Quinuclidine-boranes as intermediates in formation and isolation of functionalized quinuclidine systems

  1987cited by this paper
• Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster.

  1985cited by this paper
• The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

  1984cited by this paper
• The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.

  1984cited by this paper
• Squalene synthetase. Inhibition by an ammonium analogue of a carbocationic intermediate in the conversion of presqualene pyrophosphate to squalene

  1982cited by this paper
• Untersuchungen in der Chinuclidin‐Reihe. 3. Mitteilung. 3‐Chinuclidin‐carbonsäure

  1954cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• The Hydrogen Chloride Cleavage of the C—Si Bond in Some Dibenzothienyl-silicon Compounds

  1951cited by this paper

• Selenocyanate‐Containing Molecules as Trypanosoma cruzi Inhibitors: Impact of Regioisomerism, Conformational Restriction, and Second‐Ring Substitution

  2025cites this paper
• Inhibitors of Farnesyl Diphosphate Synthase and Squalene Synthase: Potential Source for Anti-Trypanosomatidae Drug Discovery

  2023cites this paper
• Imidazole hydrochloride promoted synthesis of 3,5-disubstituted-1,2,4-oxadiazoles

  2021cites this paper
• Synthesis, Characterization and In vitro Evaluation of N-Substituted- Sulfomoyl-Phenyl-Amino Carboxylic Acid Derivatives as Squalene Synthase Inhibitors

  2019cites this paper
• DESIGN AND SYNTHESIS OF DIBENZYLFURAN BASED ETHER AND ESTER DERIVATIVES AS POTENTIAL P450 INHIBITORS.

  2018cites this paper
• Design of α7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.

  2016cites this paper
• An efficient synthesis of highly functionalized fluorenes and fluorenothiazines

  2016cites this paper
• An Efficient Approach towards the Synthesis, Crystal Structures, DFT and Cytotoxic Activity of Highly Congested 11-Aryl-10,12-Dihydrodiindino[1,2-b‘,2′,1′-e]Pyridine

  2016cites this paper
• Inhibition of Cholesterol Biosynthesis

  2015cites this paper
• Diazaspiro-iminosugars and polyhydroxylated spiro-bislactams: synthesis, glycosidase inhibition and molecular docking studies

  2015cites this paper
• Human isoprenoid synthase enzymes as therapeutic targets

  2014cites this paper
• Ergosterol Biosynthesis for the Specific Treatment of Chagas Disease: From Basic Science to Clinical Trials

  2013cites this paper
• Neolignans and phenylpropanoids from the roots of Piper taiwanense and their antiplatelet and antitubercular activities.

  2013cites this paper
• Discovery of novel tricyclic compounds as squalene synthase inhibitors.

  2012cites this paper
• Microwave-Assisted One-Pot Synthesis of 3-Amino-1-aryl-8-bromo-2,4-dicyano-9H-fluorenes in Water

  2011cites this paper
• Discovery of a new 2-aminobenzhydrol template for highly potent squalene synthase inhibitors.

  2011cites this paper
• Discovery of atrop fixed alkoxy-aminobenzhydrol derivatives: novel, highly potent and orally efficacious squalene synthase inhibitors.

  2011cites this paper
• Squalene synthase inhibitors: An update on the search for new antihyperlipidemic and antiatherosclerotic agents.

  2011cites this paper
• Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.

  2010cites this paper
• Enantioselective inhibition of squalene synthase by aziridine analogues of presqualene diphosphate.

  2010cites this paper
• Ergosterol biosynthesis and drug development for Chagas disease.

  2009cites this paper
• The intermediate enzymes of isoprenoid metabolism as anticancer targets.

  2009cites this paper
• Efficient and Facile Synthesis of 3-Amino-1-aryl-9H-fluorene-2,4-dicarbonitrile Under Solvent-Free Conditions

  2009cites this paper
• Genetics and molecular biology: a cholesterol-lowering drug with antibacterial properties.

  2008cites this paper
• A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence

  2008cites this paper
• Lipid-lowering (hetero)aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity.

  2008cites this paper
• Quinuclidines as selective agonists for alpha-7 nicotinic acetylcholine receptors.

  2007cites this paper
• Chemistry of quinuclidines as nitrogen bicyclic bridged‐ring structures

  2006cites this paper
• Antiproliferative activities of two novel quinuclidine inhibitors against Toxoplasma gondii tachyzoites in vitro.

  2006cites this paper
• Synthesis and biological evaluation of quinuclidine derivatives incorporating phenothiazine moieties as squalene synthase inhibitors.

  2004cites this paper
• Synthesis and biological evaluation of novel propylamine derivatives as orally active squalene synthase inhibitors.

  2004cites this paper
• In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi

  2004cites this paper
• Characteristics of the squalene synthase inhibitors produced by a Streptomyces species isolated from soils.

  2003cites this paper
• Syntheses of 3-ethylidenequinuclidine derivatives as squalene synthase inhibitors. Part 2: enzyme inhibition and effects on plasma lipid levels.

  2003cites this paper